Literature DB >> 25755593

Portal cavernoma cholangiopathy-clinical characteristics.

Ajay Duseja1.   

Abstract

Because of the presence of portal cavernoma, paracholedochal and pericholedochal varices, portal cavernoma cholangiopathy (PCC) has become an entity unique to patients with extrahepatic portal venous obstruction (EHPVO). Majority of patients with these abnormalities are asymptomatic and are incidentally detected to have the presence of biliary abnormalities on cholangiography. Minority of patients present with symptoms of chronic cholestasis with or without biliary pain or acute cholangitis related most often to the presence of biliary strictures or stones. Other than the age of the patient and duration of EHPVO, presence of gall stones and common bile duct stones are other risk factors for the causation of symptoms in patients with PCC. This review summarizes the clinical characteristics of asymptomatic and symptomatic patients with PCC giving details of the prevalence of symptoms, their risk factors and overall burden of symptomatic PCC.

Entities:  

Keywords:  CBD, common bile duct; EHPVO, extrahepatic portal venous obstruction; ERC, endoscopic retrograde cholangiography; MRCP, magnetic resonance cholangiography; NCPF, non-cirrhotic portal fibrosis; PCC, portal cavernoma cholangiopathy; PHB, portal hypertensive biliopathy; PVT, portal vein thrombosis; extrahepatic portal venous obstruction; portal biliopathy; portal hypertension

Year:  2013        PMID: 25755593      PMCID: PMC4244822          DOI: 10.1016/j.jceh.2013.05.014

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  14 in total

1.  Cholangiopathy in extrahepatic portal venous obstruction. Radiological appearances.

Authors:  B Nagi; R Kochhar; D Bhasin; K Singh
Journal:  Acta Radiol       Date:  2000-11       Impact factor: 1.990

Review 2.  Portal biliopathy.

Authors:  R Chandra; D Kapoor; A Tharakan; A Chaudhary; S K Sarin
Journal:  J Gastroenterol Hepatol       Date:  2001-10       Impact factor: 4.029

3.  Portal cholangiopathy: radiological classification and natural history.

Authors:  Elba Llop; Carmen de Juan; Susana Seijo; Angeles García-Criado; Juan G Abraldes; Jaume Bosch; Juan Carlos García-Pagán
Journal:  Gut       Date:  2011-01-26       Impact factor: 23.059

4.  Portal cavernoma-associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study.

Authors:  Bertrand Condat; Valérie Vilgrain; Tarik Asselah; Dermot O'Toole; Pierre Rufat; Magali Zappa; Richard Moreau; Dominique Valla
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

5.  Bile duct varices or "pseudo-cholangiocarcinoma sign" in portal hypertension due to cavernous transformation of the portal vein.

Authors:  Y Bayraktar; F Balkanci; B Kayhan; A Ozenç; S Arslan; H Telatar
Journal:  Am J Gastroenterol       Date:  1992-12       Impact factor: 10.864

Review 6.  Portal hypertensive biliopathy.

Authors:  Radha K Dhiman; Arunanshu Behera; Yogesh K Chawla; Jang B Dilawari; Sudha Suri
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

7.  Symptomatic portal biliopathy: a single centre experience from the UK.

Authors:  Ye Htun Oo; Simon Olliff; Geoffrey Haydon; Douglas Thorburn
Journal:  Eur J Gastroenterol Hepatol       Date:  2009-02       Impact factor: 2.566

8.  Cholangiopathy associated with portal hypertension: diagnostic evaluation and clinical implications.

Authors:  G H Malkan; S J Bhatia; K Bashir; R Khemani; P Abraham; M S Gandhi; R Radhakrishnan
Journal:  Gastrointest Endosc       Date:  1999-03       Impact factor: 9.427

9.  Pseudosclerosing cholangitis in extrahepatic portal venous obstruction.

Authors:  J B Dilawari; Y K Chawla
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

10.  Endoscopic management of biliary obstruction caused by cavernous transformation of the portal vein.

Authors:  Orhan Sezgin; Dilek Oğuz; Engin Altintaş; Ulkü Saritaş; Burhan Sahin
Journal:  Gastrointest Endosc       Date:  2003-10       Impact factor: 9.427

View more
  9 in total

1.  Hepatobiliary quiz-10 (2014).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-06

Review 2.  Large-duct cholangiopathies: aetiology, diagnosis and treatment.

Authors:  Shyam Menon; Andrew Holt
Journal:  Frontline Gastroenterol       Date:  2019-01-04

Review 3.  Portal cavernoma cholangiopathy: consensus statement of a working party of the Indian national association for study of the liver.

Authors:  Radha K Dhiman; Vivek A Saraswat; Dominique C Valla; Yogesh Chawla; Arunanshu Behera; Vibha Varma; Swastik Agarwal; Ajay Duseja; Pankaj Puri; Naveen Kalra; Chittapuram S Rameshbabu; Vikram Bhatia; Malay Sharma; Manoj Kumar; Subhash Gupta; Sunil Taneja; Leileshwar Kaman; Showkat A Zargar; Samiran Nundy; Shivaram P Singh; Subrat K Acharya; Jang B Dilawari
Journal:  J Clin Exp Hepatol       Date:  2014-02-25

Review 4.  Endoscopic management of portal cavernoma cholangiopathy: practice, principles and strategy.

Authors:  Vivek A Saraswat; Praveer Rai; Tarun Kumar; Samir Mohindra; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2013-10-22

Review 5.  Therapeutic approaches for portal biliopathy: A systematic review.

Authors:  Irene Franceschet; Alberto Zanetto; Alberto Ferrarese; Patrizia Burra; Marco Senzolo
Journal:  World J Gastroenterol       Date:  2016-12-07       Impact factor: 5.742

6.  Portal Cavernoma Mimicking Pancreatic Malignancy.

Authors:  Vivian M Ussui; Lavinia Goldstein; Enrico Souto; Cynthia Levy
Journal:  ACG Case Rep J       Date:  2018-02-28

7.  Primary Tubercular Liver Abscess Complicated by Tubercular Meningitis in Portal Cavernoma Cholangiopathy.

Authors:  Ruchir Patel; Dhaval Choksi; Prateik Poddar; Kaivan Shah; Meghraj Ingle; Prabha Sawant
Journal:  ACG Case Rep J       Date:  2016-12-21

8.  Bile duct wall calcification: A rare entity in portal cavernoma cholangiopathy.

Authors:  P N B Nitesh; B Pottakkat
Journal:  J Postgrad Med       Date:  2020 Oct-Dec       Impact factor: 1.476

Review 9.  Portal biliopathy.

Authors:  Mohammad S Khuroo; Ajaz A Rather; Naira S Khuroo; Mehnaaz S Khuroo
Journal:  World J Gastroenterol       Date:  2016-09-21       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.